Bharat Biotech completes clinical development for phase-III trials and booster doses for BBV154…
Data from both phase-III human clinical trials have been submitted for approval to National Regulatory Authorities
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.